Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG4.L Regulatory News (MIG4)

  • There is currently no data for MIG4

Interim Management Statement

15 Nov 2023 15:00

RNS Number : 5916T
Mobeus Income & Growth 4 VCT PLC
15 November 2023

MOBEUS INCOME & GROWTH 4 VCT PLC

("the Company")

LEI: 213800IFNJ65R8AQW943

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2023

Mobeus Income & Growth 4 VCT plc presents an Interim Management Statement for the quarter ended 30 September 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30September 2023

(unaudited)

At 30 June 2023

(unaudited)

Net assets attributable to shareholders

£86.63 million

£84.23 million

Shares in issue

110,556,762

110,556,762

Net asset value (NAV) per share

78.36 pence

76.19 pence

Cumulative dividends paid

158.20 pence

158.20 pence

Cumulative Total return (net asset value basis) per share since inception

236.52 pence

234.39 pence

The NAV per share has decreased by 2.17 pence in the quarter (an increase of 2.85% from the opening NAV per share).

INVESTMENT ACTIVITY DURING THE PERIOD

New Investment during the period

On 26 July 2023, the Company completed a new investment of £0.40 million into Mable Therapy, a digital health platform for speech therapy and counselling for children and young adults.

On 3 August 2023, the Company completed a new investment of £0.39 million into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

Further Investments during the period

On 4 July 2023, a follow on equity investment of £0.33 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

On 11 August 2023, a follow on loan investment of £0.12 million was made into Orri, an intensive day care provider for adults with eating disorders.

INVESTMENT ACTIVITY AFTER THE PERIOD END

There has been no activity post-quarter.

SHARE BUYBACK AFTER THE PERIOD END

On 17 October 2023, the Company purchased 525,821 of its own ordinary shares at a price of 66.68 pence per share.

All shares bought back by the Company were subsequently cancelled.

DIVIDEND DECLARED AFTER THE PERIOD END

On 5 October 2023, a second interim dividend of 6.00 pence per share in respect of the year ending 31 December 2023 was declared and was paid on 8 November 2023 to all Shareholders whose names were on the register on 13 October 2023. Payment of this interim dividend will reduce NAV per share (shown above) to 72.36 pence and increase cumulative dividends paid to 164.20 pence per share.

DIVIDEND INVESTMENT SCHEME ("DIS")

On 8 November 2023, 1,515,451 shares were allotted through the DIS during the period at a price of 70.19 pence per share.

Please note that all of the above information is unaudited.

Other than as described above, there were no material events during the period and to the date of this announcement.

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCZELFFXFLLFBV
Date   Source Headline
26th Jul 20242:00 pmRNSGENERAL MEETINGS AND MERGER RESULTS
26th Jul 20247:30 amRNSSUSPENSION OF LISTING
24th Jul 20244:15 pmRNSNet Asset Value(s)
18th Jul 20241:31 pmRNSMERGER UPDATE AND GENERAL MEETINGS
4th Jul 20247:00 amRNSTransaction in Own shares and Total Voting Rights
1st Jul 20249:43 amRNSTotal Voting Rights and Capital
18th Jun 20246:01 pmRNSPROPOSED MERGER AND OFFERS
3rd Jun 20247:00 amRNSTotal Voting Rights and Capital
28th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th May 20245:37 pmRNSResult of Annual General Meeting
20th May 20247:00 amRNSInterim Management Statement
1st May 20247:00 amRNSTotal Voting Rights and Capital
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20247:00 amRNSAnnual Financial Report
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
22nd Mar 202410:02 amRNSDirector/PDMR Shareholding
22nd Mar 202410:00 amRNSIssue of Equity and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
22nd Feb 202411:00 amRNSNet Asset Value(s)
6th Feb 20243:00 pmRNSDividend Declaration
1st Feb 202411:44 amRNSVoting Rights and Capital
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202310:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20232:00 pmRNSInterim Management Statement - replacement
15th Nov 20233:00 pmRNSInterim Management Statement
8th Nov 202310:35 amRNSDirector/PDMR Shareholding
8th Nov 202310:30 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
18th Oct 202310:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSStatement re Change of Registrar
5th Oct 20237:00 amRNSDividend Declaration
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20237:00 amRNSHalf-year Report
22nd Sep 20237:00 amRNSDirector Declaration
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:00 pmRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20232:24 pmRNSDirector/PDMR Shareholding
26th May 202312:57 pmRNSIssue of Equity and Total Voting Rights
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSInterim Management Statement
2nd May 202310:00 amRNSTotal Voting Rights
19th Apr 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.